Latest / Stock Movers / Merck Drops, Walmart Falls, Nvidia Shares Set for Decline Ahead of Earnings
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg data.
- 0:16Speaker 3: Let's take a look at some of the stocks on
- 0:18Speaker 3: the move today. Again, we've got to sell off here
- 0:19Speaker 3: in the marketplace. I'm Paul Sweny alongside Scarlet Fuoh, We're
- 0:22Speaker 3: joined by Bloomberg Christine.
- 0:24Speaker 4: Christine, what are you looking at that?
- 0:25Speaker 1: Well, Paul, we got to take a look at video,
- 0:26Speaker 1: of course, because it's not moving a lot today. Actually,
- 0:30Speaker 1: so ticker NVDA, those shares just down one tenth of
- 0:33Speaker 1: one percent, But because it is such a massive stock,
- 0:36Speaker 1: is one of the top contributors still in terms of
- 0:39Speaker 1: what's dragging the S and P five hundred down, which
- 0:41Speaker 1: remains in the green. It's been flip flopping a lot
- 0:43Speaker 1: this morning. A lot of kind of questions around what
- 0:46Speaker 1: the earnings picture is going to look like next week.
- 0:48Speaker 1: As you mentioned, it is reporting on Wednesday, and so
- 0:52Speaker 1: we have found you know that in video, earnings have
- 0:55Speaker 1: tended to be a catalyst for traders to sell, particularly
- 0:58Speaker 1: in that period three to five days after the results, right,
- 1:02Speaker 1: and so this time around Bloomer Intelligence, expecting in video
- 1:05Speaker 1: to once again beat estimates both for fiscal third quarter
- 1:09Speaker 1: and their fourth quarter guidance. And they're looking specifically at
- 1:12Speaker 1: demand for their GB three hundred chip and more focus
- 1:16Speaker 1: on their hyperscular capital spending. We know that that was
- 1:19Speaker 1: twenty seven billion dollars higher in the second half and
- 1:22Speaker 1: also ninety billion for twenty twenty six.
- 1:25Speaker 4: So we're going to be focusing on those figures.
- 1:26Speaker 1: Next week, and that's Wednesday, after the closing bell exactly.
- 1:29Speaker 4: Okay, what's next on your list?
- 1:30Speaker 1: We are to take a look at M and A
- 1:32Speaker 1: Friday with Merk here. So this deal, so those shares
- 1:36Speaker 1: now in the green, so ticker MRK shares are now
- 1:40Speaker 1: in the greed as I.
- 1:40Speaker 4: Mentioned, just like slightly one to one percent.
- 1:43Speaker 1: It was down earlier as investors trying to pars what
- 1:46Speaker 1: this means for MERK specifically, we know that they have
- 1:49Speaker 1: agreed to acquire Sidar Therapeutics nine point two billion dollars.
- 1:53Speaker 1: They're going to be paying two hundred and twenty one
- 1:55Speaker 1: fifty per share in that offer, which is more than
- 1:59Speaker 1: twice a Thursday closing price. And I think the focus
- 2:03Speaker 1: here is the fact that Merk is trying to position
- 2:05Speaker 1: for flu treatment specifically because they did suffer that loss
- 2:10Speaker 1: of their patent in the cancer space, but maybe something
- 2:15Speaker 1: that they can make up for in the flu treatment space,
- 2:17Speaker 1: and our blooming intelligence analysts also pointing out that listen,
- 2:21Speaker 1: this is like a first in class product in the
- 2:23Speaker 1: space in terms of flu solutions, and also perhaps reflecting that,
- 2:29Speaker 1: you know, there's still a little bit of malaise over
- 2:32Speaker 1: vaccines in the US, so maybe something that Merk can
- 2:34Speaker 1: capitalize on.
- 2:35Speaker 3: All right, ma, go on the terminal to see who's
- 2:37Speaker 3: getting paid here, the investment banker for Merk via Base Securities,
- 2:42Speaker 3: and the investment bankers for Sidera Therapeutics ever Court in
- 2:46Speaker 3: Goldman Sachs. So people getting paid there.
- 2:49Speaker 4: What's next. Let's take a look at Walmart.
- 2:51Speaker 1: Big news there, so those shares ticker WMT and shares
- 2:55Speaker 1: are down one point six percent at the moment. The
- 2:57Speaker 1: big news, of course, is that CEO Doug mcmilli will
- 3:00Speaker 1: retire in February and he's going to be replaced by
- 3:02Speaker 1: John Ferner, which is, you know, as expected. Ferner has
- 3:06Speaker 1: long been viewed as McMillan's heir apparent, and you know
- 3:10Speaker 1: he's going to be the expectation is that he's going
- 3:12Speaker 1: to be a continuity sort of a successor, right, Like,
- 3:16Speaker 1: there's not really a lot of change expected here, and
- 3:20Speaker 1: you know, I think the focus is still whether they're
- 3:22Speaker 1: going to be able to maintain those market share games
- 3:25Speaker 1: that they've enjoyed recently, in the consistency in their performance,
- 3:29Speaker 1: And question really for Ferner is that is he going
- 3:32Speaker 1: to be able to extend the technology first sort of
- 3:35Speaker 1: focus that his successor pioneered. Right So McMillan went from
- 3:39Speaker 1: what he was an hourly worker at Walmart and then
- 3:41Speaker 1: he was credited for their digital transformation. So whether Ferner
- 3:45Speaker 1: is going to be able to continue that or evolve
- 3:48Speaker 1: that beyond what his successor has done is going to
- 3:50Speaker 1: be a question.
- 3:51Speaker 2: This stock Mover's report from Bloomberg Radio. Check back with
- 3:55Speaker 2: us throughout the day for the latest roundup of companies
- 3:58Speaker 2: making news on Wall Street and for the latest market
- 4:01Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:06Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:09Speaker 2: the Bloomberg Business app.